Search - tctmd.com

Displaying 1 - 20 of 281

Sort: Relevancy | Date

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

December 26, 2017

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

News Daily News

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

December 20, 2017

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

December 15, 2017

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

News Daily News

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

December 15, 2017

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments

News Daily News

High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments

December 14, 2017

Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG

News Daily News

Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG

December 11, 2017

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

News Daily News

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

Yael L. Maxwell

December 07, 2017

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

Burden of Readmission High in PAD Patients Following Revascularization

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

December 04, 2017

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

News Daily News

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

December 01, 2017

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

News Daily News

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

November 30, 2017

TCTMD’s Top 10 Most Popular Stories for November 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

November 29, 2017

A Visit With a Cardiologist May Improve A-fib Outcomes

News Daily News

A Visit With a Cardiologist May Improve A-fib Outcomes

November 28, 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Radial Access Best for PCI Following Thrombolysis in STEMI

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

News Conference News AHA 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

November 16, 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.